prostate cancerquality of lifeuniversal questionaryрак предстательной железыкачество жизни больныхуниверсальный опросник1.1. Лоран О.Б. Рак простаты: современный взгляд на проблему. В сб.: Матери- алы XI съезда урологов России. М., 2007. с. 5—13.Лоран О.Б. Рак простаты: современный взгляд на проблему. В сб.: Матери- алы XI съезда урологов России. М., 2007. с. 5—13.2.2. Marberger M. Current prostate cancer: 20 years later. Br J Urol Intern 2007;100(Suppl 2):11—4.Marberger M. Current prostate cancer: 20 years later. Br J Urol Intern 2007;100(Suppl 2):11—4.3.3. Jemal A., Murray T., Ward E. et al. Cancer statistics, 2005. CA Cancer J. Clin 2005;55:10.Jemal A., Murray T., Ward E. et al. Cancer statistics, 2005. CA Cancer J. Clin 2005;55:10.4.4. Новик А. А. Концепция исследования качества жизни в медицине. СПб.: ЭЛБИ, 1999.Новик А. А. Концепция исследования качества жизни в медицине. СПб.: ЭЛБИ, 1999.5.5. Gill T.M., Feinstein A.R. A critical appraisal of the quality-of-life measure- ment. JAMA 1994;272(8):619—26.Gill T.M., Feinstein A.R. A critical appraisal of the quality-of-life measure- ment. JAMA 1994;272(8):619—26.6.6. WHOQOL Group, Division of Mental Heals, World Health Organization. Study protocol for the World Health Organization: organization to develop a Quality of Life assessment instrument (WHOQOL). J Qual Life Res 1993;2(2):153—9.WHOQOL Group, Division of Mental Heals, World Health Organization. Study protocol for the World Health Organization: organization to develop a Quality of Life assessment instrument (WHOQOL). J Qual Life Res 1993;2(2):153—9.7.7. Cella D.F., Tulsky D.S. Quality of life in cancer: definition, purpose, and method of measurement. Cancer Invest 1993;11(3):327—36.Cella D.F., Tulsky D.S. Quality of life in cancer: definition, purpose, and method of measurement. Cancer Invest 1993;11(3):327—36.8.8. Giyar G.H. Feeny D.K., Patrick D.L. Measuring health-related quality of life. Ann Intern Med 1993;118(8):622—9.Giyar G.H. Feeny D.K., Patrick D.L. Measuring health-related quality of life. Ann Intern Med 1993;118(8):622—9.9.9. Tulsky D.S. An introduction to test theory. Oncology 1990;4(5):43—8.Tulsky D.S. An introduction to test theory. Oncology 1990;4(5):43—8.10.0. Bergner M., Bobbitt К.A., Carter W.B. et al. The sickness impact profile: development and final revision of a health status measure. Med Care 1981;19(8):787—805.Bergner M., Bobbitt К.A., Carter W.B. et al. The sickness impact profile: development and final revision of a health status measure. Med Care 1981;19(8):787—805.11.11. Moinpour C.M., Feigl P., Metch B. et al. Quality of life end points in cancer clinical trials: review and recommendations. J Natl Cancer Inst 1989;81(7):485—95.Moinpour C.M., Feigl P., Metch B. et al. Quality of life end points in cancer clinical trials: review and recommendations. J Natl Cancer Inst 1989;81(7):485—95.12.12. Kaplan R.M., Ganiats T.G., Sieber W.J. et al. The quality of well-being scale: critical similarities and differences with SF-36. Int J Qual Health Care 1998.;10(6):509—20.Kaplan R.M., Ganiats T.G., Sieber W.J. et al. The quality of well-being scale: critical similarities and differences with SF-36. Int J Qual Health Care 1998.;10(6):509—20.13.13. Aaronson N.К., Ahmedzai S., Bergman В. et al. The European Organization for Research and Treatment of Cancer QLQC30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85(5):365—76.Aaronson N.К., Ahmedzai S., Bergman В. et al. The European Organization for Research and Treatment of Cancer QLQC30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85(5):365—76.14.14. Cella D.F., Tulsky D.S. The Functional Assessment of Cancer Therapy scale: devel- opment and validation of the general meas- ure. J Clin Oncol 1993;11(3):570—9.Cella D.F., Tulsky D.S. The Functional Assessment of Cancer Therapy scale: devel- opment and validation of the general meas- ure. J Clin Oncol 1993;11(3):570—9.15.15. Schag C.A., Heinrich R.L. Development of a comprehensive quality of life measurement tool: CARES. Oncology 1990;4(5):135—8.Schag C.A., Heinrich R.L. Development of a comprehensive quality of life measurement tool: CARES. Oncology 1990;4(5):135—8.16.16. Litwin M.S., Hays R.D., Fink A. et al. The UCLA Prostate Cancer Index: devel- opment, reliability, and validity of a healthrelated quality of life measure. Med Care 1998;36(7):1002—12.Litwin M.S., Hays R.D., Fink A. et al. The UCLA Prostate Cancer Index: devel- opment, reliability, and validity of a healthrelated quality of life measure. Med Care 1998;36(7):1002—12.17.17. Augustin H., Pummer К., Daghofer F. et al. Patient self-reporting questionnaire on urological morbidity and bother after radical retropubic prostatectomy. Eur Urol 2002;42(2):112—7.Augustin H., Pummer К., Daghofer F. et al. Patient self-reporting questionnaire on urological morbidity and bother after radical retropubic prostatectomy. Eur Urol 2002;42(2):112—7.18.18. Wei J.Т., Dunn R.L., Litwin M.S. et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of healthre- lated quality of life in men with prostate cancer. Urology 2000;56(6):899—905.Wei J.Т., Dunn R.L., Litwin M.S. et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of healthre- lated quality of life in men with prostate cancer. Urology 2000;56(6):899—905.19.19. Streiner D.L, Norman G.R. Health Measurement Scales. 2nd ed. New York: Oxford University Press, 1995.Streiner D.L, Norman G.R. Health Measurement Scales. 2nd ed. New York: Oxford University Press, 1995.